U.S. Insurance Stock News

In January 2026, Broad Arrow, a Hagerty company, auctioned the iconic 1992 Benetton B192-05 Formula One car that carried Michael Schumacher to his first Grand Prix victory, as part of its Global Icons: Europe Online Auction. This sale of a historically important, manual-gearbox F1 car that had never before been publicly offered highlights Hagerty’s growing reach in high-end collector car auctions and motorsport memorabilia. Next, we’ll examine how showcasing Schumacher’s first Grand...

Event driven snapshot of UL Solutions With no single headline event setting the tone, UL Solutions (ULS) is drawing attention as investors reassess its business model, which focuses on testing, inspection, certification, and software, along with its recent share performance. See our latest analysis for UL Solutions. Recent trading has been supportive, with UL Solutions’ share price at $84.38 after a 1 month share price return of 8.35% and a 1 year total shareholder return of 72.49%. This...

Earnings growth puts Bright Horizons in focus Bright Horizons Family Solutions (BFAM) is back on investor radars after reporting earnings per share growth of 74% over the past year and 161% across three years. Analysts expect annual earnings expansion of 18% over the next three years. See our latest analysis for Bright Horizons Family Solutions. At a share price of $102.46, Bright Horizons has seen a 5.88% 90 day share price return; however, its 1 year total shareholder return of a 10.26%...

Alibaba stock context and recent performance snapshot Alibaba Group Holding (BABA) has been trading with some recent pressure, with the share price showing a 2.3% decline over the past day and a 3.1% decline over the past week. Across longer windows, the stock shows a 3.0% decline over the past month and a 9.5% decline over the past 3 months, while the 1 year total return stands at 90.6% based on the latest data. See our latest analysis for Alibaba Group Holding. The recent 1 day and 30 day...

SoFi Technologies (SOFI) is back in focus after a $1.5b equity sale and additional underwriter share issuance, which raised fresh capital but also heightened investor attention on dilution and already full valuation multiples. See our latest analysis for SoFi Technologies. Those capital raises and the latest $1.5b stock offering have come after a huge run, with the 1 year total shareholder return at 93.64% and the 3 year total shareholder return above 4x. However, recent share price returns...

Immunocore Holdings (IMCR) has come into focus after its appearance at the 44th Annual J.P. Morgan Healthcare Conference, where it outlined 2026 goals and highlighted cash resources supporting its clinical pipeline. See our latest analysis for Immunocore Holdings. Despite the conference update and recent rating upgrade, Immunocore’s share price return over the past month shows a 10.33% decline. Its 1 year total shareholder return of 8.55% contrasts with a 3 year total shareholder return...

Nike (NKE) is back in focus after CEO Elliott Hill and other insiders bought millions of dollars in shares, a move drawing attention to the company’s ongoing turnaround efforts and current stock performance. See our latest analysis for NIKE. At a share price of US$65.92, Nike has a 7 day share price return of 4.17%, but a 1 year total shareholder return decline of 5.24% and a 3 year total shareholder return decline of 46.05%. This points to short term momentum building, while longer term...

Strategy (MSTR) has been in focus after MSCI kept Bitcoin heavy firms in its flagship indexes, which eased concerns about forced selling, while the company continued adding to its Bitcoin holdings despite large unrealized losses. See our latest analysis for Strategy. At a share price of US$157.33, Strategy’s recent moves around MSCI’s index decision and fresh Bitcoin purchases sit against a sharp 90 day share price return decline of 50.13% and a very large 3 year total shareholder return of...

In recent trading, MasTec reported record third-quarter revenue and a larger backlog, yet management cautioned that permitting delays and shifting customer spending can cause significant quarter-to-quarter swings in margins and cash flow. This mix of strong activity and operational uncertainty highlights how timing issues in major infrastructure projects can materially influence MasTec’s near-term financial profile. Next, we’ll examine how these permitting and spending-related margin swings...

MSA Safety (MSA) recently topped analysts’ revenue and earnings expectations for the quarter, supported by steady demand in gas detection and protective headgear. This has put the stock’s latest move into sharper focus for investors. See our latest analysis for MSA Safety. That quarterly beat sits alongside a 7.1% 30 day share price return and a 7.2% year to date share price return at a latest share price of $173.98. The 1 year total shareholder return of 12.8% and 3 year total shareholder...

Vertiv Holdings Co (VRT) is back in focus after fresh analyst upgrades, strong data center demand, a US$1b PurgeRite acquisition, and new AI centric industry reports that have put its infrastructure portfolio under a brighter spotlight. See our latest analysis for Vertiv Holdings Co. Despite a recent 7 day share price return decline and some volatility around US$163.58, Vertiv’s roughly 27% 1 year total shareholder return and very large 3 year total shareholder return suggest momentum has...

What EastGroup Properties stock’s recent performance suggests for investors With no single headline event setting the tone, EastGroup Properties (EGP) has been drawing attention for its recent share performance and fundamentals, prompting investors to reassess how this industrial REIT fits into their portfolios. See our latest analysis for EastGroup Properties. At a share price of $184.06, EastGroup Properties has posted a 9.01% 90 day share price return and a 22.37% 1 year total shareholder...

In early January 2026, Otter Tail Corporation’s Board of Directors approved a 10% increase in the quarterly common stock dividend to $0.5775 per share, lifting the annual indicated dividend to $2.31 and marking the 88th consecutive year of dividend payments. This latest hike, the second straight year of double-digit dividend growth, underscores the company’s long-running emphasis on consistent cash returns alongside its mix of regulated utility, manufacturing, and plastics operations. We’ll...

Liquidia recently reported preliminary 2025 results showing strong uptake of its newly launched pulmonary hypertension drug YUTREPIA, with over 2,800 unique patient prescriptions and US$148.30 million in net product sales, including US$90.10 million in the fourth quarter alone. An interesting angle for investors is that YUTREPIA’s performance has already generated over US$30.00 million in positive fourth-quarter cash flow, giving Liquidia additional financial flexibility to expand its...

In early 2026, Deutsche Bank resumed coverage of retail stocks and issued a positive rating on Ulta Beauty, citing solid top-line momentum, improved consumer conditions, and easing policy headwinds as key supports for the sector. This renewed endorsement underscores how Ulta Beauty is being grouped with retailers seen as relatively resilient, particularly where pricing and margin conditions appear more favorable. We’ll now examine how Deutsche Bank’s constructive stance on Ulta Beauty and...

Policy shock pushes Rocket Companies higher Rocket Companies (RKT) moved sharply higher after President Donald Trump proposed a US$200 billion government backed mortgage bond purchase program, a policy idea aimed at lowering mortgage rates and easing pressures on housing affordability. See our latest analysis for Rocket Companies. That policy jolt capped a strong run, with Rocket Companies’ 1 day share price return of 9.65% contributing to a 30 day share price return of 24.48% and a 1 year...

Recent analyst coverage has focused on Centessa Pharmaceuticals (CNTA) after Needham and Oppenheimer highlighted the company’s orexin agonist pipeline and noted a planned clinical expansion, including key ORX-750 and follow-on program trials. See our latest analysis for Centessa Pharmaceuticals. Analyst enthusiasm around the orexin pipeline comes after a mixed short term stretch for the stock, with a 30 day share price return of a 15.43% decline, set against a 1 year total shareholder return...

JPMorgan’s new coverage of TIC Solutions (TIC), highlighting its technical depth and acquisition integrations, has put the stock in focus as investors weigh cross-selling prospects and planned cost synergies against a recent earnings miss. See our latest analysis for TIC Solutions. The JPMorgan coverage has arrived after a choppy stretch for TIC Solutions, with a 90 day share price return of a 10.2% decline but a year to date share price return of 15.77%. The 1 year total shareholder return...

In recent days, CRH has continued its US$300.00 million share buyback programme, repurchasing and cancelling tens of thousands of shares while preparing to report year-over-year earnings growth and highlighting new infrastructure and product initiatives in the US market. These actions, combined with CRH’s U.S.-centered listing and growing exposure to infrastructure and innovative materials, underline how capital allocation and market positioning are shaping the company’s longer-term...

Rhythm Pharmaceuticals recently reported preliminary unaudited 2025 results showing IMCIVREE net product revenues of about US$57 million in the fourth quarter and US$194 million for the full year, both reflecting solid growth versus earlier periods. An interesting aspect of this update is that roughly two-thirds of IMCIVREE revenue still comes from the U.S., underlining how central that market remains to Rhythm’s commercial story even as global sales expand. We’ll now examine how this...

CACI International Inc. recently announced it had secured a five-year task order worth up to US$212 million to modernize software-defined enterprise-level base area networks across 14 U.S. Space Force installations under the USAF Base Infrastructure Modernization contract vehicle. At the same time, the company’s board saw turnover with the resignation of William L. Jews and the appointment of retired Chief of Naval Operations Michael Gilday and former Northrop Grumman CFO David Keffer, while...

In early January 2026, Alpha Modus announced a landmark agreement with DXC Technology to roll out financial services kiosks for underbanked consumers across the US, alongside DXC unveiling AMBER, an automotive software platform aiming to cut infotainment development time and costs for carmakers. Together, these moves highlight DXC’s push into higher-value financial technology services and software-defined vehicle solutions, extending its reach beyond traditional IT outsourcing. We’ll now...

nCino (NCNO) has just posted a quarterly report with revenue and EPS guidance ahead of analyst expectations, while also emphasizing progress in its AI capabilities, yet the share price eased slightly after the release. See our latest analysis for nCino. Even with the earnings beat and AI commentary, nCino’s recent share price return has been relatively muted. The 7 day share price return is 3.85% and the 90 day share price return is 3.60%, while the 1 year total shareholder return of negative...

Recently, Citizens began covering Tri Pointe Homes with a "Market Outperform" rating, coinciding with a fall in average two-year fixed mortgage rates below 4% and management comments about encouraging early demand signs for 2025 despite a weaker backlog. This combination of a new supportive analyst view, easing financing costs for buyers and cautious management optimism has sharpened investor attention on how Tri Pointe might perform if housing demand continues to stabilize. Next, we’ll...